﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Journal of Renal Injury Prevention</JournalTitle>
      <Issn>2345-2781</Issn>
      <Volume>13</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2024</Year>
        <Month>01</Month>
        <DAY>29</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>On the occasion of World Cancer Day 2024; focus on hypertension and anti-cancer agents</ArticleTitle>
    <FirstPage>e32259</FirstPage>
    <LastPage>e32259</LastPage>
    <ELocationID EIdType="doi">10.34172/jrip.2024.32259</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Parisa</FirstName>
        <LastName>Tajdini</LastName>
      </Author>
      <Author>
        <FirstName>Majid</FirstName>
        <LastName>Foroutan</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3691-2365</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jrip.2024.32259</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>10</Month>
        <Day>22</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>12</Month>
        <Day>25</Day>
      </PubDate>
    </History>
    <Abstract>Oncohypertension is a relatively recent concept that refers to the development of elevated blood pressure in patients with cancer, which is driven by the tumor itself. This review article aims to provide an overview of oncohypertension, including its pathophysiology, clinical implications, diagnostic approaches, and management strategies. The study discusses the association between oncological disorders and hypertension, highlighting the underlying mechanisms responsible for the development of oncohypertension. Furthermore, various diagnostic methods, including imaging techniques and laboratory tests, are discussed in detail. Finally, treatment options for oncohypertension, including both pharmacological and non-pharmacological approaches, are thoroughly reviewed to optimize blood pressure control and improve patient outcomes</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Oncohypertension</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">High blood pressure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Cancer</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Blood pressure</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pathophysiology</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diagnosis</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>